The medicinal properties of Cannabis sativa and indica have been known for centuries. More recently, the class of phytocannabinoid compounds, which are exclusive to the cannabis plant, have been recognized as the primary bioactive compounds. Over 100 different cannabinoids have been identified and characterized in the cannabis plant. Under the Oregon Medical Marijuana Program, medical cannabis must be analyzed for the levels of Δ9-Tetrahydrocannabinol (THC), Δ9-Tetrahydrocannabinolic acid (THC-A), Cannabidiol (CBD), and Cannabinol (CBN) before it can be sold in a dispensary. These compounds, especially CBD, have many known medical uses, such as anticonvulsive, anti-anxiety, and antimicrobial activity. In this project we analyzed medical cannabis flowers, grown locally in Eastern Oregon, for THC, THC-A, CBD, and CBN. In addition to analyzing flowers, other forms of cannabis medicines were tested, including edibles, concentrates, and waxes.

Extraction and quantitation of cannabinoids in locally grown medicinal cannabis flowers and other extraction products

251st National Meeting (2016)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.